Jacques‐Louis Binet

2.5k citations
21 papers · 1.8k indexed · 1 hit paper · h-index 12

Impact in

Papers in

Jacques‐Louis Binet

20 papers receiving 1.7k citations

Hit Papers

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study 2002 · 707 citations
7072002202620102018200400600

Peers

Jacques‐Louis Binet
Comparison fields: 5 of 86
  • Genetics 1.3k
  • Pathology and Forensic Medicine 1.1k
  • Immunology 684
  • Hematology 330
  • Oncology 277
Replace Bruno Cazin with:
Bruno Cazin France
Karim Maloum France
Cheson Bd United States
Gregory A. Threatte United States
Evdoxia Hatjiharissi United States
Nicole Lamanna United States
Kai Uwe Chow Germany
Paula Cramer Germany
Kena C. Miller United States
Nikolaos Anagnostopoulos Greece
Jacques‐Louis Binet relative to Bruno Cazin France Bruno Cazin's profile →
Citations per field
00.5×1.5×
Bruno Cazin · 1×
Citations per year

Countries citing papers authored by Jacques‐Louis Binet

Since Specialization
Citations

This map shows the geographic impact of Jacques‐Louis Binet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques‐Louis Binet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques‐Louis Binet more than expected).

Fields of papers citing papers by Jacques‐Louis Binet

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques‐Louis Binet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques‐Louis Binet. The network helps show where Jacques‐Louis Binet may publish in the future.

Co-authors

The 25 scholars most cited alongside Jacques‐Louis Binet, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Jacques‐Louis Binet Line = papers co-authored together Jacques‐Louis Binet links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20071
2 20061
3 2002125
4 2001298
5 20019
6 199927
7 1998323
8 19972
9 199633
10 199646
11 199420
12 199116
13 19898
14 19892
15
Le sang et les hommes
19884
16
La Création vagabonde
19861
17 19862
18 197937
19 197816
20 197491

About Jacques‐Louis Binet

Jacques‐Louis Binet is a scholar working on Genetics, Pathology and Forensic Medicine, Immunology, Hematology and Physiology, having authored 21 papers that have together received 1.8k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (11 papers), Lymphoma Diagnosis and Treatment (9 papers), Immunodeficiency and Autoimmune Disorders (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Statistical Methods in Clinical Trials (1 paper), Mast cells and histamine (1 paper) and Open Education and E-Learning (1 paper). The work is most often cited by research in Genetics (1.3k citations), Pathology and Forensic Medicine (1.1k citations), Immunology (684 citations), Hematology (330 citations) and Oncology (277 citations). Jacques‐Louis Binet has collaborated with scholars based in France, United Kingdom and Japan. Frequent co-authors include R. Kanti, Bret Wacker, John C. Byrd, Michael J. Keating, Maher Albitar, Lee Brettman, Ian W. Flinn, P. Santabárbara, Vinay Jain and Peter Hillmen. Their work appears in journals such as Blood, British Journal of Haematology, Cytometry, New England Journal of Medicine and Leukemia Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026